Clinical trials: Congenital Toxoplasmosis
Toxoplasmosis, Toxoplasma Infections
Diagnosis of Toxoplasma Gondii Infection by Exploration of Cellular Immunity (TOXCELL)
Toxoplasmosis is a parasitic disease caused by Toxoplasma gondii and transmitted to humans through the consumption of raw or undercooked infected meat and / or by poorly washed vegetables.
- Conditions
- Toxoplasmosis, Toxoplasma Infections, Toxoplasmosis, Congenital, Toxoplasmosis Recurrent
- Trial name
- TOXCELL (NCT04825600)
- Testing
- anti-Toxoplasma gondii IgG and IgM dosage, cellular test
- Where
- France
- Volunteers
- 66 people, healthy volunteers welcome
- Sponsor
- Centre Hospitalier Universitaire de Nice
Congenital Toxoplasmosis, Retinochoroiditis
Pregnancy and Congenital Toxoplasmosis
The Toxoplasma gondii parasite causes toxoplasmosis. It is characterized by persistent cysts mostly localised in the brain and ocular areas. In the case of immunodeficiency, those cysts are likely to reactivate.
- Trial name
- GRETA (NCT05774496)
- Testing
- Estimation of the occurrence of retinochoroiditis in women with congenital toxoplasmosis and previous retinochoroiditis lesions (recurrence) during pregnancy and postpartum.
- Where
- France
- Volunteers
- 76 people
- Sponsor
- Hospices Civils de Lyon
Congenital Toxoplasmosis
Prevention of Congenital Toxoplasmosis With Pyrimethamine + Sulfadiazine Versus Spiramycine During Pregnancy
Background : When a mother contracts toxoplasmosis during pregnancy, the parasite may be transmitted from to her unborn child. This results in congenital toxoplasmosis, which may cause damage to the eyes and nervous system of the…
- Trial name
- TOXOGEST (NCT01189448)
- Testing
- Pyrimethamine/Sulfadiazine, Spiramycine
- Where
- France
- Volunteers
- 149 people
- Sponsor
- Assistance Publique - Hôpitaux de Paris
Congenital Toxoplasmosis
New Diagnostic Approach for Congenital Toxoplasmosis
Caused by Toxoplasma gondii, toxoplasmosis is mostly asymptomatic except in immunocompromised individuals and infants infected in utero.
- Trial name
- TOXODIAG (NCT03385499)
- Testing
- blood additional samples
- Where
- 3 sites in France
- Volunteers
- 70 people, healthy volunteers welcome
- Sponsor
- Assistance Publique - Hôpitaux de Paris
Toxoplasmosis, Congenital
Lyon Cohort of Maternal and Congenital Toxoplasma Infections
Several decades ago, France has made the choice to implement a national prevention program for congenital toxoplasmosis. The identification in their first trimester of pregnancy of all pregnant women who are susceptible to…
- Trial name
- NCT02936921
- Where
- France
- Volunteers
- 4,030 people
- Sponsor
- Hospices Civils de Lyon
Toxoplasmosis
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
RATIONALE: Congenital toxoplasmosis is an infection caused by the parasitic organism Toxoplasma gondii, and it may be passed from an infected mother to her unborn child.
- Trial name
- NCT00004317
- Testing
- Leucovorin calcium, Pyrimethamine, Spiramycin
- Where
- United States
- Volunteers
- 600 people
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
Congenital Toxoplasmosis
Assessment of Two Therapeutic Strategies in the Treatment of Children With Congenital Toxoplasmosis
Toxoplasmosis is a benign disease in healthy adults, but can be serious in the case of contamination during pregnancy: the parasite can pass through the placental barrier and infect the foetus.
- Trial name
- TOSCANE (NCT01202500)
- Testing
- reducing treatment to 3 months, registered length of treatment
- Where
- France
- Volunteers
- 302 people
- Sponsor
- Centre Hospitalier Universitaire Dijon